Saad M. Alqahtani

Dr. Saad M. Alqahtani

Surgery, College of medicine, Majmaah University, Riyadh, Ar Riyāḑ, Saudi Arabia
orcid
Associate Professor of Surgery

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Gland Surgery
Verified
Journal Article
Open access
PDF file
SASaad M. Alqahtani
Saad M. Alqahtani
HAHamed I. Albalawi
Hamed I. Albalawi
YAYousef S. Alalawi
Yousef S. Alalawi
AAAreej A. AlFattani
Areej A. AlFattani
SASaif S. Al-Sobhi
Saif S. Al-Sobhi
Background: The association between malignancy risk and nodule size in indeterminate thyroid nodules (ITNs) remains controversial. Thus, we aimed to explore the impact of nodule size as a predictor of cancer in patients with ITNs. Methods: This cross-sectional study assessed 113 patients who underwent surgical intervention for ITNs, comparing two groups based on nodule size (≥4 or <4 cm). The correlation between nodule size and malignancy risk was examined. Other variables of interest included demographics, thyroid-stimulating hormone (TSH) levels, type of surgery, and ultrasound features. Results: Of the 113 patients, 88.5% were aged <55 years, 76.1% were women, and 65.5% had nodules <4 cm. Mean nodule size was 3.4±2.3 cm. There was no significant correlation between malignancy risk and nodule size (P=0.55). An association was observed between <4 cm nodules and elevated TSH levels (P=0.03) and between ≥4 cm nodules and the presence of hypervascularity (P=0.04). Nodules <4 cm were more likely to have extrathyroidal extension, lymphovascular invasion, and positive margins than those ≥4 cm; however, this was not significant. Conclusions: Our findings showed no association between nodule size and malignancy risk, suggesting that size alone is not a predictor of cancer development. Further prospective studies are required to confirm these results.

20 April 2022 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
SASaad M. Alqahtani
Saad M. Alqahtani
MRMusaed Rayzah
Musaed Rayzah
AMAhmed Al Mutairi
Ahmed Al Mutairi
MAMohammed Alturiqy
Mohammed Alturiqy
AHAhmed Hendam
Ahmed Hendam
MMMaraei Bin Makhashen
Maraei Bin Makhashen
Introduction: Papillary carcinoma originating from a thyroglossal cyst is rare and peculiar, with majority of cases detected after surgery. Despite an excellent prognosis, its management remains controversial. Herein, we report the case of a 53-year-old woman who underwent Sistrunk procedure for a thyroglossal duct cyst and was subsequently confirmed to have papillary thyroid carcinoma. Presentation of case: A 53-year-old woman presented with an anterior midline neck mass for 7 years. The patient had no symptoms of hypo-or hyperthyroidism. Additionally, she had no history of compressive symptoms. Neck ultrasound revealed a well-defined 3.5 cm × 2.2 cm × 3 cm-sized cystic lesion inferior to the hyoid bone, with a peripheral solid component. Neck computed tomography revealed a well-defined 3.7 cm × 3.4 cm × 2.7 cm-sized cystic lesion with an enhanced central solid component with focal calcifications, inferior to the hyoid bone, and in contact with the anterior wall of the thyroid cartilage. Sistrunk procedure was performed. The patient was then diagnosed with papillary thyroid carcinoma with TNM stage pT2 and underwent total thyroidectomy as a follow-up procedure. Discussion: Thyroglossal duct cyst carcinoma is usually detected in the fourth decade of life with a higher prevalence in women. Neck ultrasound is performed during the initial radiological workup to assess the cyst and confirm the presence of the thyroid gland. Conclusion: The Sistrunk procedure is highly effective in low-risk patients. A more aggressive approach is required for high-risk patients. Highlights:

12 January 2023 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
SASaad M. Alqahtani
Saad M. Alqahtani
HAHanan R. Al-Sohabi
Hanan R. Al-Sohabi
MRMusaed F. Rayzah
Musaed F. Rayzah
AAAmani S. Alatawi
Amani S. Alatawi
AAAreej A. AlFattani
Areej A. AlFattani
YAYousef S. Alalawi
Yousef S. Alalawi
Objectives: To determine the incidence and possible risk factors of recurrent laryngeal nerve injury, to provide a relevant literature review of studies from other centers in Saudi Arabia, and to present basic statistical data for future studies in our local community. Methods: A retrospective study enrolled patients who were surgically treated for thyroid disease between January 2015 and December 2021. For concerns during the procedure, direct laryngoscopy was carried out before extubation to assess the vocal cords. Similarly, indirect laryngoscopy was carried out for patients who developed postoperative voice changes. All patients were evaluated clinically 2-3 weeks after surgery. Nerve monitors were not used in either case. Results: The study examined 437 participants: 361 (82.6%) female and 76 (17.4%) male individuals. The incidence of recurrent laryngeal nerve injury was 1.1%. The demographic characteristics, pathology (benign vs. malignant), and extent of thyroidectomy were not significantly associated with the risk of recurrent laryngeal nerve injury. Conclusion: A recurrent laryngeal nerve injury is a serious complication, and further studies are required to determine the safest techniques for thyroidectomy. However, centralization of thyroid surgery in high-volume centers might reduce this risk.

27 January 2021 in Clinical Case Reports
Verified
Journal Article
Open access
PDF file
SASaad M. Alqahtani
Saad M. Alqahtani
SASultan Alanesi
Sultan Alanesi
YAYousef Alalawi
Yousef Alalawi
The combination of TH and PHPT or PTC is extremely rare. A better comprehension of the normal anatomy of the thyroid gland and its variations, congenital anomalies, and related pathologies is essential for safe surgical intervention.

10 May 2022 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
SASaad M. Alqahtani
Saad M. Alqahtani
SASultan F. Alanesi
Sultan F. Alanesi
WMWaqas S. Mahmood
Waqas S. Mahmood
YMYassin M. Moustafa
Yassin M. Moustafa
LMLaila M. Moharram
Laila M. Moharram
YAYousef S. Alalawi
Yousef S. Alalawi
Objectives: To estimate the risk of malignancy in indeterminate thyroid nodules and to determine whether certain clinical or radiological parameters can predict the risk of malignancy. Methods: This retrospective study enrolled all adult patients (age ≥14 years) with a cytological diagnosis of atypia/follicular lesion of undetermined significance and follicular neoplasm/suspicious for a follicular neoplasm between January 2014 and January 2020. Fifty patients with surgically treated primary thyroid nodules, documented final histological diagnosis, and ultrasound examination records were included. Thyroid nodules were evaluated radiologically using Thyroid Imaging Reporting and Data System introduced by the American College of Radiology (2017). Results: Forty-two (84.0%) female and 8 (16.0%) male patients were enrolled in the study. The malignancy risks were 44.8% for Bethesda III and 28.6% for Bethesda IV. The malignancy risks for the Thyroid Imaging Reporting and Data System categories were 33.3% (TR2), 39.1% (TR3), 35.3% (TR4), and 50% (TR5). No significant associations were observed between age, gender, Bethesda category, and Thyroid Imaging Reporting and Data System and the risk of malignancy. Conclusion: None of the clinical or radiological characteristics evaluated in this study contributed to the cancer risk stratification of thyroid nodules with indeterminate cytology. A prospective multicenter study is needed to better understand cytologically indeterminate thyroid nodules.

17 July 2023 in Saudi Medical Journal
Verified
Journal Article
Open access
PDF file
SASaad M. Alqahtani
Saad M. Alqahtani
The management of cytologically indeterminate thyroid nodules remains debatable as their malignancy is difficult to establish. Most nodules have benign postoperative histology, but an accurate assessment of their proclivity for malignant transformation is crucial. Numerous studies have investigated the effects of various tools, including clinical, radiological, and cytological features, as well as biochemical and molecular markers, on the management of these heterogeneous nodules. Collectively, strategies aim to treat malignant nodules and avoid unnecessary surgery for asymptomatic benign nodules. Currently, no clear guidelines for the optimal management of cytologically indeterminate thyroid nodules exist to determine whether a conservative approach with long-term observation or surgical intervention should be selected. Thus, personalized approaches have been recommended. Large-scale multicenter prospective studies are needed to elucidate controversial issues. As this topic has not been comprehensively covered based on publications from the Gulf region, this review aims to shed light on remaining controversies.